Jazz Pharmaceuticals is making a $7.2 billion bet on the future of medical cannabis.
The drugmaker said on Wednesday it will acquire GW Pharma, the maker of CBD-based epilepsy treatment Epidiolex, …
Read More
Jazz Pharmaceuticals is making a $7.2 billion bet on the future of medical cannabis.
The drugmaker said on Wednesday it will acquire GW Pharma, the maker of CBD-based epilepsy treatment Epidiolex, …
Read More